MRI and Technetium-99m Hexamethylpropylene Amine Oxime Labeled Leucocyte Scintigraphy in the Diagnosis and Differentiation between Acute Osteomyelitis and Neuroarthropathy in the Diabetic Foot
GEHAN G. ALI, M.D., R., Y. HEMIMY, M.D., M. (2020). MRI and Technetium-99m Hexamethylpropylene Amine Oxime Labeled Leucocyte Scintigraphy in the Diagnosis and Differentiation between Acute Osteomyelitis and Neuroarthropathy in the Diabetic Foot. EKB Journal Management System, 88(March), 495-504. doi: 10.21608/mjcu.2020.104599
REEM H. BASSIOUNY, M.D.; GEHAN G. ALI, M.D.; MONA Y. HEMIMY, M.D.. "MRI and Technetium-99m Hexamethylpropylene Amine Oxime Labeled Leucocyte Scintigraphy in the Diagnosis and Differentiation between Acute Osteomyelitis and Neuroarthropathy in the Diabetic Foot". EKB Journal Management System, 88, March, 2020, 495-504. doi: 10.21608/mjcu.2020.104599
GEHAN G. ALI, M.D., R., Y. HEMIMY, M.D., M. (2020). 'MRI and Technetium-99m Hexamethylpropylene Amine Oxime Labeled Leucocyte Scintigraphy in the Diagnosis and Differentiation between Acute Osteomyelitis and Neuroarthropathy in the Diabetic Foot', EKB Journal Management System, 88(March), pp. 495-504. doi: 10.21608/mjcu.2020.104599
GEHAN G. ALI, M.D., R., Y. HEMIMY, M.D., M. MRI and Technetium-99m Hexamethylpropylene Amine Oxime Labeled Leucocyte Scintigraphy in the Diagnosis and Differentiation between Acute Osteomyelitis and Neuroarthropathy in the Diabetic Foot. EKB Journal Management System, 2020; 88(March): 495-504. doi: 10.21608/mjcu.2020.104599